Transmission-Blocking Activities of Quinine, Primaquine, and Artesunate
Antimicrobial Agents and Chemotherapy 50(6): 1927-1930
Article 2006 English
Authors
KC
Kesinee Chotivanich
JS
Jetsumon Sattabongkot
RU
Rachanee Udomsangpetch
Abstract
1 min read
The infectivity of Plasmodium falciparum gametocytes after exposure in vitro to quinine, artesunate, and primaquine was assessed in Anopheles dirus , a major vector of malaria in Southeast Asia. Mature gametocytes (stage 5) of a Thai isolate of P. falciparum were exposed to the drugs for 24 h in vitro before membrane feeding to A. dirus . After 10 days, the mosquito midguts were dissected and the oocysts were counted. In this system, artesunate showed the most potent transmission-blocking activity; the mean (standard deviation [SD]) 50% and 90% effective concentrations (EC 50 , and EC 90 , respectively, in nanograms per milliliter) were 0.1 (0.02) and 0.4 (0.15), respectively. Transmission-blocking activity of quinine and primaquine was observed at relatively high concentrations (SDs): EC 50 of quinine, 642 (111) ng/ml; EC 50 of primaquine, 181 (23) ng/ml; EC 90 of quinine, 816 (96) ng/ml; EC 90 of primaquine, 543 (43) ng/ml. Artesunate both prevents the maturation of immature P. falciparum gametocytes and reduces the transmission potential of mature gametocytes. Both of these effects may contribute to reducing malaria transmission.
Victor Chaumeau, Praphan Wasisakun, James A Watson, Thidar Oo, Sarang Aryalamloed, Mu Phang Sue, Gay Nay Htoo, Naw Moo Tha, Laypaw Archusuksan, Sunisa Sawasdichai, Gornpan Gornsawun, Somya Mehra, Sir Nicholas White, François Nosten
Victor Chaumeau, Praphan Wasisakun, James A Watson, Thidar Oo, Sarang Aryalamloed, Mu Phang Sue, Gay Nay Htoo, Naw Moo Tha, Laypaw Archusuksan, Sunisa Sawasdichai, Gornpan Gornsawun, Somya Mehra, Sir Nicholas White, François Nosten
Achaporn Yipsirimetee, Pornpawee Chiewpoo, Rupam Tripura, Dysoley Lek, Nicholas Day, Arjen M. Dondorp, Sasithon Pukrittayakamee, Sir Nicholas White, Kesinee Chotivanich
Discussion(0)
No comments yet. Be the first to comment.